You don’t want to miss this interview. Dr. Gamble shares an important component of the investigative process within her institution and how it is used to help discern poor practice from suspected diversion. She gives a great look at what has worked well for them and I know you will come away with an idea or two.
Our guest: Ronald Chapman II, Esq. LLM, Chapman Law Group, Safe Harbor Group In today’s episode we explore crtical issues in healthcare compliance and regulation.
Our guest: Heidi Bragg, MBA, RPh, Drug Diversion Specialist Texas Children’s Hospital Drug diversion monitoring in healthcare often focuses heavily on nursing units, but what
Our guest: Neil Braun, BSC (Pharm), BA (Hons), MPP, Director, PHSA Allied Health Professional Practice Provincial Health Services Authority Drug diversion in healthcare settings is
© Copyright 2023. All Rights Reserved.
